Science Explorer Back to mapMap
Discussion
Company · Hadera · Israel

Regentis Biomaterials (Israel)

regentis.co.ilROR OpenAlex
Research works
5
▼ 18% vs 2018-21
Citations
233
45.3 per fractional work
Top-10% rate
9.0%
all institutions 10.0%
Open access
57%
world 40%
International
81%
world 18%
Regentis Biomaterials (Israel)

Not ranked overall: Regentis Biomaterials (Israel) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Regentis Biomaterials (Israel) work in?

In all years, 50% of research at Regentis Biomaterials (Israel) is in Health Sciences, 42% in Physical Sciences. Its largest fields are Medicine (37%), Materials Science (20%), Engineering (17%). It does 1.3× the world's share of Health Sciences.

Health Sciences: 3 fractional works · 50.3% of its workMedicine: 2 fractional works · 37.3% of its workSurgery: 1 fractional works · 11.5% of its workRheumatology: 1 fractional works · 10.5% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 4.1% of its workEpidemiology: 0 fractional works · 3.9% of its workOrthopedics and Sports Medicine: 0 fractional works · 3.3% of its workUrology: 0 fractional works · 2.1% of its workOtorhinolaryngology: 0 fractional works · 1.4% of its workRehabilitation: 0 fractional works · 0.6% of its workDentistry: 0 fractional works · 8.9% of its workGeneral Dentistry: 0 fractional works · 3.3% of its workOrthodontics: 0 fractional works · 3.3% of its workOral Surgery: 0 fractional works · 2.3% of its workHealth Professions: 0 fractional works · 4.1% of its workEmergency Medical Services: 0 fractional works · 3.3% of its workHealth Information Management: 0 fractional works · 0.8% of its workPhysical Sciences: 2 fractional works · 41.7% of its workMaterials Science: 1 fractional works · 20.2% of its workBiomaterials: 1 fractional works · 18.3% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 1.2% of its workMaterials Chemistry: 0 fractional works · 1.0% of its workEngineering: 1 fractional works · 17.3% of its workBiomedical Engineering: 1 fractional works · 17.3% of its workChemistry: 0 fractional works · 2.5% of its workOrganic Chemistry: 0 fractional works · 1.6% of its workInorganic Chemistry: 0 fractional works · 1.0% of its workEnvironmental Science: 0 fractional works · 1.0% of its workWater Science and Technology: 0 fractional works · 1.0% of its workComputer Science: 0 fractional works · 0.8% of its workArtificial Intelligence: 0 fractional works · 0.8% of its workLife Sciences: 0 fractional works · 8.0% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 6.4% of its workMolecular Medicine: 0 fractional works · 6.4% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.6% of its workPharmaceutical Science: 0 fractional works · 1.6% of its workALL ITS WORKRegentisBiomaterials…5fractional works, all years
Life Sciences8%Physical Sciences42%Health Sciences50%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 10 fields, with their numbers
    1. Medicine237.3%
    2. Dentistry08.9%
    3. Health Professions04.1%
    1. Materials Science120.2%
    2. Engineering117.3%
    3. Chemistry02.5%
    4. Environmental Science01.0%
    5. Computer Science00.8%
    1. Biochemistry, Genetics and Molecular Biology06.4%
    2. Pharmacology, Toxicology and Pharmaceutics01.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.13× its world share, 0 worksBiochemistry, Geneti…Pharmacology, Toxicology and Pharmaceutics: 21.44× its world share, 0 worksPharmacology, Toxico…Chemistry: 3.04× its world share, 0 worksChemistryEngineering: 0.95× its world share, 0 worksEngineeringMaterials Science: 12.42× its world share, 0 worksMaterials ScienceDentistry: 13.77× its world share, 0 worksDentistryMedicine: 0.35× its world share, 0 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 21.4×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics21.44×0 works
  2. Dentistry13.77×0 works
  3. Materials Science12.42×0 works
  4. Biochemistry, Genetics and Molecular Biology3.13×0 works
  5. Chemistry3.04×0 works
  6. Engineering0.95×0 works
  7. Medicine0.35×0 works

What are the most cited papers from Regentis Biomaterials (Israel)?

The most cited paper from Regentis Biomaterials (Israel) is "Morphological and compositional monitoring of a new cell-free cartilage repair hydrogel technology – GelrinC by MR using semi-quantitative MOCART scoring and quantitative T2 index and new zonal T2 index calculation" (Siegfried Trattnig, Kitty Ohel, Vladı́mir Mlynárik et al., 2015), with 61 citations. Next come "Protein composition alters in vivo resorption of PEG-based hydrogels as monitored by contrast-enhanced MRI" (39) and "Monitoring 111 In-labelled polyisocyanopeptide (PIC) hydrogel wound dressings in full-thickness wounds" (34).

Most cited papers
#PaperReleasedCitations
1 Morphological and compositional monitoring of a new cell-free cartilage repair hydrogel technology – GelrinC by MR using semi-quantitative MOCART scoring and quantitative T2 index and new zonal T2 index calculation Siegfried Trattnig, Kitty Ohel, Vladı́mir Mlynárik et al. · Osteoarthritis and Cartilage Open access 14 Jul 2015 61
2 Protein composition alters in vivo resorption of PEG-based hydrogels as monitored by contrast-enhanced MRI Alexandra Berdichevski, Yonatan Shachaf, Roni Wechsler et al. · Biomaterials 9 Dec 2014 39
3 Monitoring 111 In-labelled polyisocyanopeptide (PIC) hydrogel wound dressings in full-thickness wounds Roel C. op ‘t Veld, Lieke Joosten, Onno I. van den Boomen et al. · Biomaterials Science Open access 2019 34
4 Steric Interference of Adhesion Supports In-Vitro Chondrogenesis of Mesenchymal Stem Cells on Hydrogels for Cartilage Repair Revital Goldshmid, Shlomit Cohen, Yonatan Shachaf et al. · Scientific Reports Open access 28 Sep 2015 27
5 Management of Patellofemoral Arthritis: From Cartilage Restoration to Arthroplasty Brian A. Mosier, Elizabeth A. Arendt, Diane Lynn Dahm et al. · Journal of the American Academy of Orthopaedic Surgeons 21 Sep 2016 24
All 9 most cited papers, with filters and sorting

Which research topics does Regentis Biomaterials (Israel) publish most on?

By volume in 2022-now: Hydrogels: synthesis, properties, applications, Nanocomposite Films for Food Packaging, Advanced Cellulose Research Studies and Advanced Drug Delivery Systems.

Hydrogels: synthesis, properties, applications: 0 fractional worksNanocomposite Films for Food Packaging: 0 fractional worksAdvanced Cellulose Research Studies: 0 fractional worksAdvanced Drug Delivery Systems: 0 fractional worksSinusitis and nasal conditions: 0 fractional worksDental Implant Technique…0Dental Implant Techniques and Outcomes: 0 fractional worksNanoparticle-Based Drug Delivery: 0 fractional worksBone Tissue Engineering Materials: 0 fractional works
Molecular MedicineBiomaterialsPharmaceutical ScienceOtorhinolaryngology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hydrogels: synthesis, properties, applications Molecular Medicine 0 works
  2. 2 Nanocomposite Films for Food Packaging Biomaterials 0 works
  3. 3 Advanced Cellulose Research Studies Biomaterials 0 works
  4. 4 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
  5. 5 Sinusitis and nasal conditions Otorhinolaryngology 0 works
  6. 6 Dental Implant Techniques and Outcomes Oral Surgery 0 works
  7. 7 Nanoparticle-Based Drug Delivery Biomaterials 0 works
  8. 8 Bone Tissue Engineering Materials Biomedical Engineering 0 works
  9. 9 Advanced Nanomaterials in Catalysis Materials Chemistry 0 works
  10. 10 Metal-Organic Frameworks: Synthesis and Applications Inorganic Chemistry 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available57.4%not open42.6%

World: 40% of research is openly available.

with international co-authors80.6%domestic only19.4%

World: 18% is written across borders.

How has Regentis Biomaterials (Israel)'s research output changed?

Output in 2022-2025 was 18% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Hadera

All research institutions in Hadera

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Regentis Biomaterials (Israel). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.